Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.
HMGB1 (high-mobility group box 1) protein, a pleiotropic cytokine released by several cell types under physiological and pathological conditions, has been identified as a signal molecule active on A431 cells. Although extracellular HMGB1 itself does not trigger any detectable signalling effect on these cells, it induces an increased susceptibility to EGF (epidermal growth factor) stimulation. Specifically, at concentrations of EGF which promote undetectable or limited cell responses, the addition of sub-nanomolar concentrations of HMGB1 potentiates the effect of EGF by specifically activating a downstream pathway that leads to enhanced cell motility through an increase in Ca2+ influx, activation of extracellular-signal-regulated kinase 1/2 and remodelling of the actin cytoskeleton. These results, which identify extracellular HMGB1 as an activator of human tumour cell migration operating in concert with EGF, have important implications in the search for novel strategies to control tumour progression and metastatic invasion.
Sparatore
Bianca
B
Department of Experimental Medicine, Biochemistry Section and Centre of Excellence for Biomedical Research, University of Genoa, Viale Benedetto XV, 1-16132 Genoa, Italy. traspar@unige.it
Patrone
Mauro
M
Passalacqua
Mario
M
Pedrazzi
Marco
M
Ledda
Sabina
S
Pontremoli
Sandro
S
Melloni
Edon
E
D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects*; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D024243:HMGB1 Protein / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D011485:Protein Binding
D024243:HMGB1 Protein; D004815:Epidermal Growth Factor; D002118:Calcium
Biochem J. 1996 Nov 15;320 ( Pt 1):253-6
8947495
J Cell Sci. 1999 Apr;112 ( Pt 8):1149-58
10085250
Nature. 2000 May 18;405(6784):354-60
10830965
J Cell Biol. 2000 May 29;149(5):995-8
10831602
J Biol Chem. 2000 Dec 22;275(51):40096-105
11007787
J Exp Med. 2000 Aug 21;192(4):565-70
10952726
J Cell Biol. 2001 Mar 19;152(6):1197-206
11257120
EMBO J. 2001 Aug 15;20(16):4337-40
11500360
Exp Cell Res. 2002 Jan 1;272(1):84-91
11740868
J Biol Chem. 2002 Mar 1;277(9):7021-8
11748221
Biochem J. 2002 May 1;363(Pt 3):529-35
11964153
Gastroenterology. 2002 Sep;123(3):790-802
12198705
Blood. 2003 Apr 1;101(7):2652-60
12456506
J Cell Biochem. 2003 Aug 15;89(6):1126-37
12898511
FEBS Lett. 2003 Oct 9;553(1-2):11-7
14550538
J Cell Biol. 2004 Feb 2;164(3):441-9
14744997
J Intern Med. 2004 Mar;255(3):320-31
14871456
J Intern Med. 2004 Mar;255(3):332-43
14871457
J Intern Med. 2004 Mar;255(3):344-50
14871458
J Intern Med. 2004 Mar;255(3):351-66
14871459
J Biol Chem. 2004 Feb 27;279(9):7370-7
14660645
Free Radic Biol Med. 2004 Mar 1;36(5):555-64
14980700
J Biol Chem. 2004 Mar 26;279(13):12988-96
14711810
J Biol Chem. 2004 Mar 26;279(13):12967-73
14726535
Br J Pharmacol. 2004 Jun;142(4):635-46
15172963
Blood. 2004 Aug 15;104(4):1174-82
15130941
Anal Biochem. 1976 May 7;72:248-54
942051
Biochemistry. 1981 Oct 13;20(21):6280-6
6272837
Cell. 1992 Apr 17;69(2):295-303
1314702
Exp Cell Res. 1992 Jun;200(2):444-51
1369684
J Biol Chem. 1993 Jan 25;268(3):1960-4
8380583
FEBS Lett. 1995 Jul 24;368(3):466-70
7635200
FEBS Lett. 1996 May 20;386(2-3):95-8
8647297
Neuroscience. 1998 Feb;82(4):1021-8
9466426
FEBS Lett. 1998 Jul 10;431(1):55-8
9684864
Biochem Biophys Res Commun. 1998 Sep 18;250(2):430-5
9753647
Biochem J. 1999 Jan 1;337 ( Pt 1):113-8
9854032
FEBS Lett. 1997 Jan 6;400(3):275-9
9009213